**Core Concept**
Idiopathic Thrombocytopenic Purpura (ITP) is an autoimmune disease characterized by low platelet count due to platelet destruction and impaired platelet production. The primary goal of treatment is to increase platelet production or decrease platelet destruction.

**Why the Correct Answer is Right**
The best treatment for ITP is first-line corticosteroids, specifically prednisone, which works by suppressing the immune system and reducing antibody-mediated platelet destruction. Corticosteroids also increase thrombopoietin production, which stimulates megakaryocytes to produce more platelets. However, in cases of steroid-refractory or steroid-dependent ITP, other treatments like rituximab or splenectomy may be considered.

**Why Each Wrong Option is Incorrect**
**Option A:** Splenectomy is not the first-line treatment for ITP, but it can be considered in cases of severe thrombocytopenia or refractory disease. It works by removing the spleen, which is the primary site of platelet destruction.
**Option B:** Rituximab is a monoclonal antibody that targets CD20-positive B cells and is used as an alternative treatment for ITP, particularly in steroid-refractory cases. However, it is not the first-line treatment.
**Option C:** Platelet transfusions are not a standard treatment for ITP, as they do not address the underlying cause of the disease and can actually worsen thrombocytopenia.

**Clinical Pearl / High-Yield Fact**
Corticosteroids are the first-line treatment for ITP due to their ability to suppress the immune system and increase thrombopoietin production, leading to improved platelet counts.

**Correct Answer:** A. Prednisone.